Zentalis Pharmaceuticals ... (ZNTL)
NASDAQ: ZNTL
· Real-Time Price · USD
1.59
0.11 (7.43%)
At close: Aug 15, 2025, 3:59 PM
1.56
-2.19%
After-hours: Aug 15, 2025, 07:25 PM EDT
Zentalis Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 26.86M | n/a | n/a | 40.56M | 2.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 160K | 262K | 317K | 321K | 327K | 324K | 337K | 348K | 344K | 360K | 359K | 375K | 348K | 344K | 209K | 137K | 119K | 79K |
Gross Profit | -160K | -262K | 26.86M | -321K | -327K | 40.24M | 1.77M | -348K | -344K | -360K | -359K | -375K | -348K | -344K | -209K | -137K | -119K | -79K |
Operating Income | -36.06M | -45.62M | -49.85M | -51.43M | -65.15M | -24.77M | -67.92M | -62.72M | -103.92M | -64.95M | -51.75M | -54.19M | -63.46M | -57.88M | -48.19M | -62.87M | -55.13M | -50.35M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.21K | 4.45K | n/a | 493.00 | 1.91K | n/a | n/a | n/a | n/a | n/a | 143K |
Pretax Income | -26.87M | -48.28M | -47.68M | -40.19M | -88.01M | 10.18M | -61.07M | -55.51M | -99.47M | -60.84M | -48.52M | -52.29M | -63.04M | -57.45M | -48.1M | -11.19M | -55.02M | -50.25M |
Net Income | -26.87M | -48.28M | -47.47M | -40.16M | -88.28M | 10.07M | -60.92M | -55.53M | -112.53M | -60.95M | -48.16M | -52.13M | -63.05M | -57.49M | -50.06M | -4.19M | -54.57M | -49.9M |
Selling & General & Admin | 8.45M | 10.58M | 40.01M | 14.61M | 16.76M | 15.42M | 16.03M | 15.95M | 15.66M | 16.37M | 11.14M | 12.01M | 19.64M | 11.77M | 9.75M | 8.87M | 10.36M | 11.95M |
Research & Development | 27.61M | 27.25M | 32.97M | 36.82M | 48.39M | 49.59M | 51.56M | 46.77M | 42.68M | 48.58M | 40.62M | 42.18M | 43.83M | 46.11M | 38.44M | 54M | 44.77M | 38.39M |
Other Expenses | n/a | 7.8M | 3.74M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -44K |
Operating Expenses | 36.06M | 45.62M | 76.71M | 51.43M | 65.15M | 65M | 67.58M | 62.72M | 58.35M | 64.95M | 51.75M | 54.19M | 63.46M | 57.88M | 48.19M | 62.87M | 55.13M | 50.35M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 345K | 365.1K | 4.46M | 739K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -324K | -337K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 36.06M | 45.62M | 76.71M | 51.43M | 65.15M | 65.33M | 67.92M | 62.72M | 58.35M | 64.95M | 51.75M | 54.19M | 63.46M | 57.88M | 48.19M | 62.87M | 55.13M | 50.35M |
Income Tax Expense | n/a | n/a | -205K | -27K | 266K | 143K | -135K | 31K | -605K | 108K | -360K | -159K | 17K | 33K | 159K | -697K | 45K | 196K |
Shares Outstanding (Basic) | 71.99M | 71.68M | 71.24M | 71.11M | 71.04M | 70.9M | 70.77M | 70.61M | 60.79M | 59.28M | 59.28M | 56.81M | 51.12M | 45.24M | 44.98M | 44.61M | 40.74M | 40.36M |
Shares Outstanding (Diluted) | 71.99M | 71.68M | 71.24M | 71.11M | 71.04M | 71.19M | 70.77M | 70.61M | 60.79M | 59.28M | 59.28M | 56.81M | 51.12M | 45.24M | 44.98M | 44.61M | 40.74M | 40.36M |
EPS (Basic) | -0.37 | -0.67 | -0.67 | -0.56 | -1.24 | 0.14 | -0.86 | -0.79 | -1.85 | -1.03 | -0.81 | -0.92 | -1.23 | -1.27 | -1.11 | -0.09 | -1.34 | -1.24 |
EPS (Diluted) | -0.37 | -0.67 | -0.67 | -0.56 | -1.24 | 0.14 | -0.86 | -0.79 | -1.85 | -1.03 | -0.81 | -0.92 | -1.23 | -1.27 | -1.11 | -0.09 | -1.34 | -1.24 |
EBITDA | -35.9M | -45.62M | -45.8M | -51.11M | -64.82M | -24.44M | -67.58M | -62.37M | -58M | -64.59M | -51.4M | -53.82M | -63.11M | -57.53M | -47.9M | -62.73M | -55.01M | -50.27M |
EBIT | -36.06M | -37.83M | -46.11M | -51.43M | -65.15M | -24.77M | -67.92M | -62.72M | -58.35M | -64.95M | -51.75M | -54.19M | -63.46M | -57.88M | -48.19M | -62.87M | -55.13M | -50.35M |
Depreciation & Amortization | 160K | 262K | 317K | 321K | 327K | 324K | 337K | 348K | 344K | 360K | 359K | 375K | 348K | 344K | 209K | 137K | 119K | 79K |